{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:56:21Z","timestamp":1790290581725,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Colorado Bioscience Discovery Evaluation Grant Program"},{"name":"National Institute of Health","award":["R21-AI121581"],"award-info":[{"award-number":["R21-AI121581"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejmech.2016.09.034","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T17:31:10Z","timestamp":1473701470000},"page":"130-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Tetracyclic indolines as a novel class of \u03b2-lactam-selective resistance-modifying agent for MRSA"],"prefix":"10.1016","volume":"125","author":[{"given":"Yugen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakota","family":"Cleaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica D.","family":"Podoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.09.034_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.sjbs.2013.12.007","article-title":"What if Fleming had not discovered penicillin?","volume":"21","author":"Alharbi","year":"2014","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2016.09.034_bib2","series-title":"Nobel Lecture on Penicillin","author":"Fleming","year":"1947"},{"key":"10.1016\/j.ejmech.2016.09.034_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/cr030102i","article-title":"Bacterial resistance to \u03b2-lactam antibiotics:\u2009 compelling opportunism, compelling opportunity","volume":"105","author":"Fisher","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2016.09.034_bib4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2016.09.034_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cid\/cit613","article-title":"Methicillin-resistant Staphylococcus aureus: an evolving pathogen","volume":"58","author":"Stryjewski","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.09.034_bib6","series-title":"Antibiotic Resistance Threats","author":"Center for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.ejmech.2016.09.034_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","article-title":"Novel classes of antibiotics or more of the same?","volume":"163","author":"Coates","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrd3975","article-title":"Platforms for antibiotic discovery","volume":"12","author":"Lewis","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.09.034_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.09.034_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1039\/c2np20035j","article-title":"Plants as Sources of new antimicrobials and resistance-modifying agents","volume":"29","author":"Abreu","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2016.09.034_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.chembiol.2012.11.013","article-title":"Discovery of wall teichoic acid inhibitors as potential anti-MRSA \u03b2-lactam combination agents","volume":"20","author":"Wang","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1126\/science.1120800","article-title":"Sampling the antibiotic resistome","volume":"311","author":"D'Costa","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2016.09.034_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrmicro1614","article-title":"The antibiotic resistome: the nexus of chemical and genetic diversity","volume":"5","author":"Wright","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nchembio.1967","article-title":"A\u00a0synthetic lethal approach for compound and target identification in Staphylococcus aureus","volume":"12","author":"Pasquina","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/ja410813j","article-title":"Lipoprotein activators stimulate Escherichia coli penicillin-binding proteins by different mechanisms","volume":"136","author":"Lupoli","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2016.09.034_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.mib.2013.06.014","article-title":"Teichoic acid biosynthesis as an antibiotic target","volume":"16","author":"Pasquina","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.chembiol.2012.11.013","article-title":"Discovery of wall teichoic acid inhibitors as potential anti-MRSA \u03b2-lactam combination agents","volume":"20","author":"Wang","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib18","doi-asserted-by":"crossref","first-page":"18909","DOI":"10.1073\/pnas.1209126109","article-title":"Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids","volume":"109","author":"Brown","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.09.034_bib19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.00879-10","article-title":"In\u00a0vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates","volume":"55","author":"Suzuki","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.09.034_bib20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biotechadv.2012.10.004","article-title":"Quorum sensing inhibitors: an overview","volume":"31","author":"Kalia","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2016.09.034_bib21","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.1073\/pnas.1316981110","article-title":"A\u00a0quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation","volume":"110","author":"O'Loughlin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.09.034_bib22","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1021\/ja069017t","article-title":"Inhibition of Pseudomonas aeruginosa biofilm formation with Bromoageliferin analogues","volume":"129","author":"Huigens","year":"2007","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2016.09.034_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2016.09.034_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13445","article-title":"Aspergillomarasmine A overcomes metallo-\u03b2-lactamase antibiotic resistance","volume":"510","author":"King","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2016.09.034_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1021\/cb5008019","article-title":"Inactivation of multiple bacterial histidine kinases by targeting the ATP-binding domain","volume":"10","author":"Wilke","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/cb400490k","article-title":"Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance","volume":"9","author":"Harris","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/bj2090229","article-title":"The inhibition of class C beta-lactamases by boronic acids","volume":"209","author":"Beesley","year":"1983","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2016.09.034_bib28","doi-asserted-by":"crossref","first-page":"e1000989","DOI":"10.1371\/journal.ppat.1000989","article-title":"Can bacteria evolve resistance to quorum sensing disruption?","volume":"6","author":"Defoirdt","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2016.09.034_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijantimicag.2007.07.015","article-title":"Introduction: historical perspective and development of amoxicillin\/clavulanate","volume":"30","author":"Geddes","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2016.09.034_bib30","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/497839","article-title":"Acquired metallo-\u03b2-lactamases: an increasing clinical threat","volume":"41","author":"Rossolini","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.09.034_bib31","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1128\/AAC.00726-12","article-title":"Broadening the spectrum of \u03b2-lactam antibiotics through inhibition of signal peptidase type I","volume":"56","author":"Therien","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.09.034_bib32","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1021\/jo400236f","article-title":"Overcoming resistance to \u03b2-lactam antibiotics","volume":"78","author":"Worthington","year":"2013","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2016.09.034_bib33","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1310459110","article-title":"Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to \u03b2-lactam Antibiotics","volume":"110","author":"Podoll","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2016.09.034_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1039\/b512615k","article-title":"Chemistry and biology of monoterpene indole alkaloid biosynthesis","volume":"23","author":"O'Connor","year":"2006","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2016.09.034_bib35","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.1002\/anie.201503736","article-title":"Gold-catalyzed cyclization leads to a bridged tetracyclic indolenine that represses \u03b2-lactam resistance","volume":"54","author":"Xu","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2016.09.034_bib36","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1016\/j.bmcl.2014.10.094","article-title":"Discovery and initial structure\u2013activity relationships of N-benzyl tricyclic indolines as antibacterials for methicillin-resistant Staphylococcus aureus","volume":"24","author":"Barbour","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.09.034_bib37","article-title":"Bio-inspired discovery of chemical reactions and biological probes","author":"Griffiths","year":"2016","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2016.09.034_bib38","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1021\/jm500146g","article-title":"Structure\u2013activity relationship studies of the tricyclic indoline resistance-modifying agent","volume":"57","author":"Chang","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.09.034_bib39","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/adsc.201501101","article-title":"Property-guided synthesis of aza-tricyclic indolines: development of gold catalysis en route","volume":"358","author":"Barbour","year":"2016","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2016.09.034_bib40","series-title":"Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria that Grew Aerobically","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"10.1016\/j.ejmech.2016.09.034_bib41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(00)04403-2","article-title":"Whole genome sequencing of meticillin-resistant Staphylococcus aureus","volume":"357","author":"Kuroda","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2016.09.034_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JCM.44.1.225-226.2006","article-title":"Community associated methicillin-resistant Staphylococcus aureus epidemic clone USA300 in isolates from Florida and Washington","volume":"44","author":"Roberts","year":"2006","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2016.09.034_bib43","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/AAC.00497-10","article-title":"Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii","volume":"54","author":"Sopirala","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.09.034_bib44","doi-asserted-by":"crossref","first-page":"38148","DOI":"10.1074\/jbc.M111.288985","article-title":"Activation of BlaR1 protein of methicillin-resistant Staphylococcus aureus, its proteolytic processing, and recovery from induction of resistance","volume":"286","author":"Llarrul","year":"2011","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416307644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416307644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T07:49:54Z","timestamp":1568360994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416307644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":44,"alternative-id":["S0223523416307644"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.034","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracyclic indolines as a novel class of \u03b2-lactam-selective resistance-modifying agent for MRSA","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}